At the beginning of the month, Lilly CEO David Ricks told Bloomberg that he expected the shortage to end very soon, adding that actually today or tomorrow we plan to exit that process. On a recent earnings call, Lilly announced that seven sites are expected to help alleviate the supply issues
Products are not intended for human consumption, injection, veterinary use, diagnostic use, therapeutic use, food use, cosmetic application, or household use
These medicines are typically administered by subcutaneous injection, though oral formulations of semaglutide are also available
During week one, the most common experience is a noticeable reduction in appetite that feels almost surreal
Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene
Efficacy and safety of lixisenatide once-daily versus placebo in patients with type 2 diabetes mellitus insufficiently controlled on sulfonylurea metformin (GetGoal-S.) [abstract 785]